APA (7th ed.) Citation

Soleimani Dodaran, M., Borgoni, S., Sofyali, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & van Kampen, A. H. C. (2020). Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. BMC cancer, 20, . https://doi.org/10.1186/s12885-020-07100-z

Chicago Style (17th ed.) Citation

Soleimani Dodaran, Maryam, Simone Borgoni, Emre Sofyali, Pernette J. Verschure, Stefan Wiemann, Perry D. Moerland, and Antoine H. C. van Kampen. "Candidate Methylation Sites Associated with Endocrine Therapy Resistance in ER+/HER2- Breast Cancer." BMC Cancer 20 (2020). https://doi.org/10.1186/s12885-020-07100-z.

MLA (9th ed.) Citation

Soleimani Dodaran, Maryam, et al. "Candidate Methylation Sites Associated with Endocrine Therapy Resistance in ER+/HER2- Breast Cancer." BMC Cancer, vol. 20, 2020, https://doi.org/10.1186/s12885-020-07100-z.